[1] 熊建琼,邓朝霞,张 雷,等. 伊曲康唑在多器官功能障碍综合征患者侵袭性真菌感染中的应用[J].第三军医大学学报, 2006, 28 (11):1260.
[2] Kontoyiannis DP,Sagar N,Hirschi KD,et al. Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae[J]. Antimicrob Agents Chemother, 1999, 43(11): 2798.
[3] 季海涛,张万年,周有骏.抗真菌药物作用靶点羊毛甾醇14α-去甲基化酶研究[J].生物化学与生物物理进展,1999,26(2):108.
[4] Phempel M. Experiences, recognitions and questions in azole antimycotics[J]. Jpn J Med Mycol, 1982, 23(1): 17.
[5] Jiang Y,Zhang J,Cao Y,et al. Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents[J]. Bioorg Med Chem Lett,2011, 21(15): 4471.
[6] Chai X,Zhang J,Cao Y,et al. Design, synthesis and molecular docking studies of novel triazole as antifungal agent[J]. Eur J Med Chem,2011, 46(7): 3167.
[7] Kolb HC,Finn MG,Sharpless KB,et al. Click chemistry: diverse chemical function from a few good reactions[J]. Angew Chem Int Ed, 2001, 40(11): 2004.
[8] Pore VS,Aher NG,Kumar M,et al. Design and synthesis of fluconazole-bile acid conjugate using cick reaction[J]. Tetrahedron 2006, 62: 11178.
[9] National Committee for Clinical Laboratory Standards.Reference method for broth dilution antifungal susceptibility testing of yeasts approved standard[S]. Document M27-A2, Wayne, PA, 2002.